Lipocine Inc.
Pharmaceutical company · Salt Lake City, Utah, United States · Nasdaq: LPCN
Lipocine Inc. is a pharmaceutical company headquartered in Salt Lake City, Utah, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker LPCN. It has reported private securities offerings to the US SEC, most recently $38 million sold in a notice filed in 2013.
Lipocine at a glance
What does Lipocine do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $38 million sold (2013).
Frequently asked questions about Lipocine
Where is Lipocine headquartered?
Lipocine Inc. is headquartered in Salt Lake City, Utah, United States.
What does Lipocine do?
Lipocine Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Lipocine a public company?
Yes. Lipocine Inc. trades on Nasdaq under the ticker LPCN.
When was Lipocine founded?
The earliest incorporation on record for Lipocine Inc. is in 2011, according to public company registers.
Similar companies
- iVeena Delivery Systems, Inc.Salt Lake City, Utah, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.